Bioline Rx reported $11.38M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Arca Biopharma USD 0 0 Mar/2025
Bio Path USD 261K 261K Mar/2025
Bioline Rx USD 11.38M 1.22M Sep/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025